Following excision of primary B16 melanoma tumors, mice were vaccinated with optTRP1455 peptide and also given TGF-β blockade to reverse the tumor and regulatory CD4+ (Treg) cell TGF-β-mediated suppression of CD8+ T cells (171). The gene discussed is TGFB1; the disease is neoplasm.